Is this a new market for Theranos?

Here’s an idea for the fallen unicorn: Animal testing. A debate broke out on Twitter this weekend about whether the blood-testing startup could pivot in the wake of a criminal probe and a federal investigation. 

Talking about Theranos with some E. Coast friends in health. Our prediction: A down round and then a pivot to animal testing.

— Christina Farr (@chrissyfarr) May 7, 2016

And some mixed responses from the experts: 

@chrissyfarr I’ve been pushing them that way!!! Huge market for rapid and easy testing in mice & huge need for small volumes

— Ethan Weiss (@ethanjweiss) May 7, 2016

@chrissyfarr tiny market

— Jonathan Hirsch (@JonathanHirsch) May 7, 2016

@ethanjweiss @chrissyfarr we were just talking about that a lab meeting yesterday! For our mouse efficacy study, blood draws can be lethal

— Ethan O. Perlstein (@eperlste) May 7, 2016

CF